AARD
NASDAQ · Pharmaceuticals
Aardvark Therapeutics Inc
$4.07
-0.83 (-16.94%)
Open$4.84
Previous Close$4.90
Day High$4.93
Day Low$4.06
52W High$17.94
52W Low$4.74
Volume—
Avg Volume381.4K
Market Cap103.64M
P/E Ratio—
EPS$-2.53
SectorPharmaceuticals
Analyst Ratings
Strong Buy
18 analysts
Price Target
+544.7% upside
Current
$4.07
$4.07
Target
$26.24
$26.24
$21.03
$26.24 avg
$41.18
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 44.31M | 42.19M | 44.45M |
| Net Income | 12.13M | 10.07M | 10.99M |
| Profit Margin | 27.4% | 23.9% | 24.7% |
| EBITDA | 17.61M | 17.80M | 18.44M |
| Free Cash Flow | 9.43M | 7.96M | 8.12M |
| Rev Growth | -1.8% | +11.1% | +14.2% |
| Debt/Equity | 0.60 | 0.62 | 0.49 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |